Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00764829 · ClinicalTrials.gov registry record
Blood Samples to Evaluate Biomarkers of Donor Chimerism
A clinical trial, sponsored by Fred Hutchinson Cancer Center.
- Completed
- Registry status
- 80
- Enrollment target
NCT00764829: Completed study, sponsored by Fred Hutchinson Cancer Center.
NCT00764829 is a clinical trial that has completed, run by Fred Hutchinson Cancer Center. The registered enrollment target is 80 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00764829 has completed, sponsored by Fred Hutchinson Cancer Center.
- COMPLETED
- Registry status
- 80 participants
- Enrollment target
Study Summary
We are interested in patient-specific factors that may affect the balance of recipient cells and donor cells in patients who receive stem cell transplants. We will look at the way the patient's body breaks down two drugs, fludarabine and mycophenolate mofetil, and how these two drugs affect the patient's body.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2008-09 |
| Est. Completion | 2012-02 |
What the finished NCT00764829 record still lists
NCT00764829 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 80 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00764829 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00764829 about?
NCT00764829 is a clinical study titled "Blood Samples to Evaluate Biomarkers of Donor Chimerism". We are interested in patient-specific factors that may affect the balance of recipient cells and donor cells in patients who receive stem cell transplants. We will look at the way the patient's body breaks down two drugs, fludarabine and mycophenolate mofetil, and how these two drugs affect the pati...
What is the current status of trial NCT00764829?
This trial is currently completed. The enrollment target is 80 participants. The study started on 2008-09. Estimated completion is 2012-02.
Who is sponsoring clinical trial NCT00764829?
This trial is sponsored by Fred Hutchinson Cancer Center, which has 483 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia